Fulcrum Therapeutics
FULC
#7824
Rank
A$0.33 B
Marketcap
$5.30
Share price
0.29%
Change (1 day)
-0.59%
Change (1 year)

P/S ratio for Fulcrum Therapeutics (FULC)

P/S ratio as of November 2024 (TTM): 2.65

According to Fulcrum Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.7909. At the end of 2024 the company had a P/S ratio of 4.72.

P/S ratio history for Fulcrum Therapeutics from 2019 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.72-96.83%
2023149148.99%
202259.759.62%
202137.42.7%
202036.4
2019N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA